MedTrace Logo

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)

NCT00504361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2016-05-02

No results posted yet for this study

Summary

This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, COPD (chronic obstructive pulmonary disease), interstitial lung disease, cystic fibrosis, and lung cancer. The investigators hope to be able to identify an association between a genetic make-up in the blood samples and the risks of developing a particular lung disease, or severity of a lung disease. The findings of this study might be important to develop future preventative methods and potential treatments for the management of lung disease.

Conditions

Sponsors & Collaborators

  • Weill Cornell Medical College in Qatar

    collaborator OTHER

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Ronald G Crystal, MD · Weill Cornell Medical College, NY and Qatar

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00504361 on ClinicalTrials.gov